UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 69

of '进展期胰腺外分泌癌的化疗'

69
TI
Randomized phase II trial comparing folfirinox (5FU/leucovorin [LV], irinotecan [I]and oxaliplatin [O]) vs gemcitabine (G) as first-line treatment for metastatic pancreatic adenocarcinoma (MPA). First results of the ACCORD 11 trial (abstract 4516)
AU
Ychou M, Desseigne F, Guimbaud R, et al
SO
J Clin Oncol. 2007;25:210s.
 
AD